Structure Info
- Chemspace ID
- CSSS00159261298 (In-Stock Screening Compounds)
- CAS
- 39524-08-8
- MFCD
- MFCD25371916
- IUPAC Name
- (2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bS)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
- Mol formula
- C47H76O18
- Mol weight
- 929 Da
- Catalog Number(s)
- 33206, 41694, 41694-0.05G, 41694-0.25G, A149084, A788600, AA00C7AH, AF69221, AG00C7D9, AN69221, AOS00C7D9, AR00C829, AS-76280, ArZ-UP487559, BBP03877, BD299812, CD32001480, CFN99766, CM1065031, CSC159261298, FA73822, HY-N0265, LN01345236, M18520, T2698, X1089, ZX-CY009335
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.13
- Heavy atoms count
- 65
- Rotatable bond count
- 10
- Number of rings
- 8
- Carbon bond saturation, Fsp3
- 0.936
- Polar surface area (Å)
- 295
- Hydrogen bond acceptors count
- 17
- Hydrogen bond donors count
- 11
- Zoom the structure
- CSSS00159261298
Items Overall 10 items from 4 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 1 mg | 23 | |
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 39 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 64 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 65 | |
Description: Names: Asperosaponin VI; Product Description: Asperosaponin VI, A saponin component from Dipsacus asper , induces osteoblast differentiation through BMP‐2/p38 and ERK1/2 pathway . Asperosaponin Ⅵ inhibits apoptosis in hypoxia-induced cardiomyocyte by increasing the Bcl-2/Bax ratio and decreasing active caspase-3 expression, as well as enhancing of p-Akt and p-CREB .; Target: Apoptosis;Caspase; CAS: 39524-08-8 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 1 mg | 24 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 41 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 67 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 68 | |
Description: Names: Asperosaponin VI; Product Description: Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities; Target: Akt;Apoptosis;Caspase;HIF/HIF Prolyl-Hydroxylase;p38 MAPK;PERK;PPAR; CAS: 39524-08-8 | ||||||
ChemFaces | 12 days | China To: | 90 | 1 mg | 6 | |
Description: CAS: 39524-08-8 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 20 mg | 60 | |
Description: Asperosaponin VI (Akebia saponin D) , the most abundant constituent of the rhizome of Dipsacus asper, has been used for the treatment of lower back pain, traumatic hematoma and bone fractures.; CAS: 39524-08-8 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire